For most people who read patents, Markush structures are fabulous things.

1200px-Markush_structure.svgz

Your mind glazes over upon finding one, casting it and the accompanying Claim 1 texts into intellectual property oblivion. Whomever the Markush structure was formulated for, it wasn’t you. But when questions relating to Markush are asked, the dangerously poor understanding of these enigmas is exposed. 

In this report, we will identify the components that make up the Markush structure and how you can exploit the value they possess. But, for chemists, there are many advantages to using Markush structures. They primarily define all the compounds that have been claimed in a patent. Therefore, a reader is able to get a complete picture of, for example, every drug candidate utilised for a particular medical condition in a clinical trial.

A Markush structure in Claim 1 of a patent would serve as legal notice to any reader that certain molecules covered within are “off-limits”—any attempts to make these compounds in a commercial setting would likely result in an infringement of that patent. A reader may also use Markush structures to distinguish compounds that have actually been synthesised by the patent holders from those that have not—so-called “prophetic” compounds, such as bioisosteres.

Downloads